Amidst the battle of the world against CoViD-19, there was a drug which shows promising results to combat this deadly Virus. This is a Chinese-based Capsule named Lianhua Quingwin Jiaonang.
In relation to CoViD-19, this product was first registered on 1st of February on The Chinese Clinical Trial Registry.
During this Trial, there was a total of 284 CoViD-19 patients from 23 Hospitals were involved.
According to its study design, the intervention given include routine treatment and four Capsules of Lianhua Quingwin each time or one bag of Lianhua Quingwin granules three times a day.
According to that said study, there was about 83.8% of the patients in the treatment group saw an improvement in their lung scan images, and 78.9% recovered.
So, what is the fuss about? What is this drug then, and how was it developed?The Lianhua Quingwin medication was first developed in China in the year 2003, specifically in response to the SARS outbreak in China. In July 2003, the first Lianhua Quingwin product and preparation method patent CN1194752C disclosed an antiviral traditional Chinese medicine composition and preparation method. The instructions in the specification confirmed that the traditional Chinese medicine composition can be used as a treatment for atypical pneumonia and prophylactic drugs. According to reports, Lianhua Quingwin had played a vital role in respiratory-related public health incidents many times since its launch. During the SARS epidemic in 2003, this anti-SARS Chinese patent medicine Lianhua Quingwin Capsule entered China’s National New Drug Fast Track as a prescription drug in May 2003. In May 2004, it obtained China’s National Pharmaceutical Standard Number and was listed by Ministry of Health of the People’s Republic of China as one of the first Chinese patent medicines for the treatment of SARS.
Coronavirus which causes SARS, MERS and CoViD-19 |
The Health Sciences Authority (HSA) which is based on Outram Road, Singapore, made statements on 12th of May 2020 that:
Lianhua Quingwin Capsule is locally registered as a proprietary Chinese medicine and this does not mean that the capsule can be used as a medicine to treat or relieve CoViD-19 symptoms. In response to an inquiry from Channel 8 News, HSA said that the authorities approved the capsule as a proprietary Chinese medicine for relieving cold and cold symptoms according to the efficacy of the ingredients of this capsule, and did not recognize this drug as a treatment or relief of CoViD-19 symptoms. They further explained that Chinese patent medicines are supplementary health products controlled by the authorities, not products approved for the treatment of infectious diseases and other conditions. So far, there is no scientific evidence that any herbal medicine can help to treat CoViD-19.
If this drug can help us be CoViD-19 free, we need more proof right?
Former Mandaluyong Mayor Benjamin Abalos Jr. was tested positive for CoViD-19. He said he is suffering from severe headache, coughing, joint pains and having a hard time breathing. Yet, now, he said he is no longer experiencing any CoViD-19 symptom, a few days after ingesting Chinese medication given to him by ex-senator Bongbong Marcos.
Former Mandaluyong Mayor Benjamin Abalos Jr. |
“Without waiting for the swabbing, I immediately took the Chinese meds Bongbong Marcos gave me (4 tablets at 4 times a day),” he wrote in a Facebook post, without specifying the name of the drug.
If this drug then can help combat CoViD-19, can this be available in the Philippines or most importantly worldwide?
The Food and Drug Administration or the FDA in the Philippines has approved this, Filipinos can now use this specific grug but not to cure CoViD-19, the Philippines will use this drug to treat lung toxins, fever and other related symptoms.
FDA Director General Eric Domingo, however, said that the Lianhua Quingwin has yet to be approved in Philippines as a treatment for the coronavirus disease.
The drug’s Certificate of Product Registration for the Philippines states that it could be used to combat heat-toxin invasion of the lungs, fever, aversion to cold, muscle soreness, and stuffy and runny nose.According to FDA Director General Eric Domingo in an interview, “It was approved last Friday, August 14 as traditional medicine. It may now be sold, prescribed, and used in the Philippines”.
Lianhua Quingwin is being sold all over the online shopping platforms at Php 200.00 per box.
The Chinese government donated 100,000 boxes of Lianhua Quingwin to Italy.
Cheerio!
Comments
Post a Comment